Spider venom the future of painkillers

Painkillers based on spider venom may be a few years away from bringing relief to neuropathic and osteoarthritis pain sufferers, according to Queensland researchers.

Researchers led by Professor Glenn King from the University of Queensland have begun isolating unique peptides that could target voltage-gated sodium channel NaV1.7, a key player in the human pain signalling pathway.

Blocking that pathway could mean an end to all